UniProt Q6P5S8
Antibody 27F3 light chain (Q6P5S8)
Antibody 27F3 light chain (UniProt Q6P5S8): 34 experimental structures on GenesisL1, 1 ligand bound, 48 pockets. Binding sites, pockets, druggability and 3D structures in GL1X.
- UniProt
- Q6P5S8
- Protein
- Antibody 27F3 light chain
- Experimental structures
- 34
- Predicted models
- 0
- Ligands
- 1
- Pockets
- 48 · 6 records with a druggable one
Structures
34 records of Q6P5S8 in the MolNFT archive: 34 experimental, 0 predicted.
| Entry | Title | Method | Chains | Ligands | Pockets |
|---|---|---|---|---|---|
| 2NXY | HIV-1 gp120 Envelope Glycoprotein(S334A) Complexed with CD4 and Antibody 17b | x-ray diffraction | C | — | — |
| 2NXY | HIV-1 GP120 envelope GLYCOPROTEIN(S334A) complexed with CD4 and antibody 17B | x-ray diffraction | C | — | — |
| 2NXZ | HIV-1 gp120 Envelope Glycoprotein (T257S, S334A, S375W) Complexed with CD4 and Antibody 17b | x-ray diffraction | C | — | — |
| 2NXZ | HIV-1 GP120 envelope glycoprotein (T257S, S334A, S375W) complexed with CD4 and antibody 17B | x-ray diffraction | C | — | — |
| 2NY0 | HIV-1 gp120 Envelope Glycoprotein (M95W, W96C, T257S, V275C, S334A, S375W, A433M) Complexed with… | x-ray diffraction | C | — | — |
| 2NY0 | HIV-1 GP120 envelope glycoprotein (M95W, W96C, T257S, V275C, S334A, S375W, A433M) complexed with… | x-ray diffraction | C | — | — |
| 2NY1 | HIV-1 gp120 Envelope Glycoprotein (I109C, T257S, S334A, S375W, Q428C) Complexed with CD4 and… | x-ray diffraction | C | — | — |
| 2NY1 | HIV-1 GP120 envelope glycoprotein (I109C, T257S, S334A, S375W, Q428C) complexed with CD4 and… | x-ray diffraction | C | — | — |
| 2NY2 | HIV-1 gp120 Envelope Glycoprotein (T123C, T257S, S334A, S375W, G431C) Complexed with CD4 and… | x-ray diffraction | C | — | — |
| 2NY2 | HIV-1 GP120 envelope glycoprotein (T123C, T257S, S334A, S375W, G431C) complexed with CD4 and… | x-ray diffraction | C | — | — |
| 2NY3 | HIV-1 gp120 Envelope Glycoprotein (K231C, T257S, E267C, S334A, S375W) Complexed with CD4 and… | x-ray diffraction | C | — | — |
| 2NY3 | HIV-1 GP120 envelope glycoprotein (K231C, T257S, E267C, S334A, S375W) complexed with CD4 and… | x-ray diffraction | C | — | — |
| 2NY4 | HIV-1 gp120 Envelope Glycoprotein (K231C, T257S, E268C, S334A, S375W) Complexed with CD4 and… | x-ray diffraction | C | — | — |
| 2NY4 | HIV-1 GP120 envelope glycoprotein (K231C, T257S, E268C, S334A, S375W) complexed with CD4 and… | x-ray diffraction | C | — | — |
| 2NY5 | HIV-1 gp120 Envelope Glycoprotein (M95W, W96C, I109C, T257S, V275C, S334A, S375W, Q428C, A433M)… | x-ray diffraction | L | — | — |
| 2NY5 | HIV-1 GP120 envelope glycoprotein (M95W, W96C, I109C, T257S, V275C, S334A, S375W, Q428C, A433M)… | x-ray diffraction | L | — | — |
| 2NY6 | HIV-1 gp120 Envelope Glycoprotein (M95W, W96C, I109C, T123C, T257S, V275C,S334A, S375W, Q428C… | x-ray diffraction | C | — | — |
| 2NY6 | HIV-1 GP120 envelope glycoprotein (M95W, W96C, I109C, T123C, T257S, V275C,S334A, S375W, Q428C… | x-ray diffraction | C | — | — |
| 5WKO | Crystal structure of antibody 27F3 recognizing the HA from A/California/04/2009 (H1N1) influenza… | x-ray diffraction | B, D, F, H, J, L | — | 2 (best 0.57) |
| 5WKO | Crystal structure of antibody 27F3 recognizing the ha from A/CALIFORNIA/04/2009 (H1N1) influenza… | x-ray diffraction | B, D, F, H, J, L | — | — |
| 6AL4 | Crystal structure of anti-CD19 antibody B43 Fab | x-ray diffraction | A, C, E | — | 18 (best 0.66) |
| 6AL4 | Crystal structure of anti-CD19 antibody B43 Fab | x-ray diffraction | A, C, E | — | — |
| 6AL5 | Complex between CD19 (N138Q mutant) and B43 Fab | x-ray diffraction | L | — | — |
| 6AL5 | Complex between CD19 (N138Q mutant) and B43 Fab | x-ray diffraction | L | — | — |
| 6UGS | Crystal structure of the Fab fragment of PF06438179/GP1111 an infliximab biosimilar in a C-centered… | x-ray diffraction | L, B | — | 8 (best 0.71) |
| 6UGS | Crystal structure of the Fab fragment of PF06438179/GP1111 an infliximab biosimilar in a C-centered… | x-ray diffraction | L, B | — | — |
| 6UGT | Crystal structure of the Fab fragment of PF06438179/GP1111 an infliximab biosimilar in a I-centered… | x-ray diffraction | L, B | — | — |
| 6UGT | Crystal structure of the Fab fragment of PF06438179/GP1111 an infliximab biosimilar in a I-centered… | x-ray diffraction | L, B | — | — |
| 6UGU | Crystal structure of the Fab fragment of anti-TNFa antibody infliximab (Remicade) in a C-centered… | x-ray diffraction | L, B | — | 6 (best 0.77) |
| 6UGU | Crystal structure of the Fab fragment of anti-tnfa antibody infliximab (remicade) in a C-centered… | x-ray diffraction | L, B | — | — |
| 6UGV | Crystal structure of the Fab fragment of anti-TNFa antibody infliximab (Remicade) in a I-centered… | x-ray diffraction | L, B | — | 11 (best 0.71) |
| 6UGV | Crystal structure of the Fab fragment of anti-tnfa antibody infliximab (remicade) in a I-centered… | x-ray diffraction | L, B | — | — |
| 6V8Z | VRC03 and 10-1074 Bound BG505 F14 HIV-1 SOSIP Envelope Trimer Structure | electron microscopy | F, L, R | NAG | 3 (best 0.70) |
| 6V8Z | VRC03 and 10-1074 bound BG505 F14 HIV-1 sosip envelope trimer structure | electron microscopy | F, L, R | NAG | — |
Ligands
- NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · in 2 records
Elsewhere
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.